摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Z(OMe)-Gly-OSu | 108304-82-1

中文名称
——
中文别名
——
英文名称
Z(OMe)-Gly-OSu
英文别名
(2,5-dioxopyrrolidin-1-yl) 2-[(4-methoxyphenyl)methoxycarbonylamino]acetate
Z(OMe)-Gly-OSu化学式
CAS
108304-82-1
化学式
C15H16N2O7
mdl
——
分子量
336.301
InChiKey
JYGBPZFSRFPTJV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.53
  • 重原子数:
    24.0
  • 可旋转键数:
    6.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    111.24
  • 氢给体数:
    1.0
  • 氢受体数:
    7.0

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    肽的研究。CXLV。合成27种残基的肽酰胺,其对应于犬胃泌素释放多肽(cGRP)的整个氨基酸序列。
    摘要:
    犬胃泌素释放多肽(cGRP,其特征为类似于蚕豆蛋白的 27 个残基的多肽)是通过连续缩合 7 个纯度已确定的多肽片段,然后在三氟乙酸中用三氟甲磺酸进行脱保护而合成的。在去保护层之前,先用苯基硫代三甲基硅烷在一定量的三氟甲磺酸三甲基硅酯催化下进行短暂处理,还原受保护 cGRP 中的 Met(O) 残基。经 HPLC 纯化的均相产物与合成的人 GRP 相似,能显著提高大鼠血浆中的免疫活性胃泌素水平。
    DOI:
    10.1248/cpb.34.4805
点击查看最新优质反应信息

文献信息

  • Studies on peptides. CXL Synthesis of human gastrin-releasing polypeptide (hGRP).
    作者:SUZUMITSU KUNO、KENICHI AKAJI、OSAMU IKEMURA、MOTOYUKI MORIGA、MITSURU AONO、KAZUHIKO MIZUTA、ATSUSHI TAKAGI、HARUAKI YAJIMA
    DOI:10.1248/cpb.34.2462
    日期:——
    Human gastrin-releasing polypeptide (hGRP), which consists of 27 amino acid residues with a C-terminal amide, was synthesized by a conventional solution method, by assembling six peptide fragments followed by deprotection with 1M trifluoromethanesulfonic acid-thioanisole in trifluoroacetic acid. Met(O) employed was reduced by treatment with phenylthiotrimethylsilane in the presence of trimethylsilyl trifluoromethanesulfonate before deprotection. The synthetic peptide was as active as synthetic porcine GRP, in terms of immunoreactive gastrin release in rats.
    人类促胃液释放多肽(hGRP)由27个氨基酸残基组成,具有C末端胺,采用常规溶液法合成,通过组装六个肽片段,并使用1M三甲烷磺酸-thioanisole在三氟乙酸中进行去保护。使用的Met(O)在去保护之前,通过在三甲基基三甲烷磺酸盐存在下,用苯基三甲基硅烷处理进行还原。合成的肽在大鼠的免疫反应性促胃液释放方面与合成的猪GRP具有相同的活性。
  • Synthesis of an immunologically active fragment analog of prothymosin .ALPHA. with enhanced enzymatic stability.
    作者:Takashi ABIKO、Hiroshi SEKINO
    DOI:10.1248/cpb.39.752
    日期:——
    A fragment analog, [D-Arg30]prothymosin α fragment 1-30, containing D-arginine in place of arginine residue at position 30 was synthesized by the liquid phase procedure and studied for immunological effect on the impaired blastogenic response of T-lymphocytes isolated from uremic patients after treatment of human serum. Deacetyl-thymosin α1, a synthetic octaeicosapeptide corresponding to deacetyl-prothymosin α fragment 1-28, has restoration ability for the impaired blastogenic response of T-lymphocytes of uremic patients but is susceptible to proteolytic digestion. On the other hand, the fragment analog, [D-Arg30]prothymosin α fragment 1-30 retained activity and was shown to exhibit a high degree of stability when incubated in human serum. These results indicate that N-terminal acetylation and the introduction of D-residue into the C-terminal residue of prothymosin α fragment 1-30 increase resistance to proteolytic degradation by exopeptidases.
    通过液相法合成了一种片段类似物[D-Arg30]胸腺肽α片段1-30,该片段含有D-精氨酸,取代了第30位的精酸残基。脱乙酰胸腺肽α1是一种与脱乙酰胸腺肽α片段1-28相对应的合成八代肽,它对尿毒症患者T淋巴细胞受损的鼓泡生成反应具有恢复能力,但易被蛋白酶消化。另一方面,片段类似物[D-Arg30]原胸腺肽α片段 1-30 保留了活性,并且在人血清中培养时表现出高度稳定性。这些结果表明,原胸腺肽α片段1-30的N端乙酰化和在C端残基中引入D-残基可增强对外肽酶蛋白分解的抵抗力。
  • Studies on peptides. CLXIV. Solution-phase synthesis of a 36-residue peptide amide corresponding to the entire amino acid sequence of chicken antral peptide.
    作者:LILI Guo、EIGORO MURAYAMA、SUSUMU FUNAKOSHI、NOBUTAKA FUJII、MITSURU AONO、MASAYUKI MATSUDA、MOTOYUKI MORIGA、HARUAKI YAJIMA
    DOI:10.1248/cpb.36.4364
    日期:——
    A 36-residue peptide amide corresponding to the entire amino acid sequence of chicken antral peptide was synthesized by assembling seven peptide fragments via the azide, followed by thioanisole-mediated deprotection with trimethylsilyl bromide and trimethylsilyl trifluoromethanesulfonate in trifluoroacetic acid.The synthetic peptide stimulated gastric secretion, but not pancreatic secretion.
    通过叠氮化物组装七个肽片段,然后在三氟乙酸中用三甲基硅烷三氟甲磺酸三甲基硅烷酯介导的茴香醚介导的去保护,合成了对应于鸡胃窦肽的整个氨基酸序列的36个残基的肽酰胺。合成的肽刺激胃液分泌,但不是胰腺分泌。
  • Studies on peptides. CL. Syntheses of (D-His2)-analogs of enkephalin and adrenorphin and several (D-Arg2)enkephalin analogs.
    作者:SUSUMU FUNAKOSHI、MINORU KUBOTA、NAOTO KOSUGA、JIAN-PING XU、HARUAKI YAJIMA、WEI LI、SHIGEKI TAMURA、SHUJI KANEKO、MASAMICHI SATOH、HIROSHI TAKAGI
    DOI:10.1248/cpb.35.2561
    日期:——
    [D-His2] Leu-enkephalin and [D-His2] adrenorphin were synthesized. In addition, eight [D-Arg2] enkephalin-related peptides were synthesized. Their inhibitory effects on electrically stimulated myenteric plexus-longitudinal muscle preparations of guinea-pig ileum were examined.
    合成了[D-His2] Leu-脑啡肽和[D-His2] 肾上腺啡肽。此外,还合成了八种[D-Arg2]脑啡肽相关肽。研究了这些肽对电刺激豚鼠回肠肠肌丛纵肌制备物的抑制作用。
  • Studies on peptides. CLIX. Preparation of a protected 33-residue peptide for the synthesis of human cholecystokinin (hCCK-33).
    作者:NOBUTAKA FUJII、SHIROH FUTAKI、SUSUMU FUNAKOSHI、KENICHI AKAJI、HIROSHI MORIMOTO、OSAMU IKEMURA、HARUAKI YAJIMA
    DOI:10.1248/cpb.36.3271
    日期:——
    A protected 33-residue peptide corresponding to the entire amino acid sequence of human cholecystokinin (hCCK-33) was synthesized by successive azide condensations of 7 peptide fragments of established purity. β-Cycloheptyl aspartate [Asp(OChp)] was employed to suppress base-catalyzed succinimide formation.
    通过连续叠氮化物缩合 7 个已确定纯度的肽片段,合成了对应于人胆囊收缩素 (hCCK-33) 完整氨基酸序列的受保护的 33 个残基肽。 β-环庚基天冬氨酸 [Asp(OChp)] 用于抑制碱催化的琥珀酰亚胺形成。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫